| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,266 | 7,459 | 2,066 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 6,266 | 7,459 | 2,066 | | | Operating Expenses | | Research Development | 10,466 | 18,824 | 9,781 | | Selling General and Administrative | 10,933 | 14,822 | 9,657 | | Non Recurring | 8,012 |
-
|
-
| | Others | 625 | 272 | 228 | | | | Total Operating Expenses | 30,035 |
-
|
-
| | | | Operating Income or Loss | (23,769) | (26,459) | (17,600) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,423 | 4,161 | 993 | | Earnings Before Interest And Taxes | (26,173) | (21,850) | (16,607) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (26,173) | (21,850) | (16,607) | | Income Tax Expense | 873 | 40 | 145 | | Minority Interest | 88 | 449 |
-
| | | | Net Income From Continuing Ops | (27,046) | (21,890) | (16,752) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (27,046) | (21,890) | (16,752) | | Preferred Stock And Other Adjustments | (757) |
-
|
-
| | | Net Income Applicable To Common Shares | ($27,803) | ($21,890) | ($16,752) |
|
0.34% Nasdaq 
0.0865 (8.30%) 
Income Statement
